Cyclo-Z

DRUG3 trials

Sponsors

VA Office of Research and Development, NovMetaPharma Co., Ltd.

Conditions

DiabetesDiabetes Mellitus Type 2 in ObeseDiabetes Mellitus, Type 2

Phase 2

Development of A Novel Anti-Hyperglycemic Agent

TerminatedNCT00878605

VA Office of Research and DevelopmentDiabetes

Start: 2010-04-01End: 2013-09-30Updated: 2018-06-14

A Study to Evaluate the Efficacy and Safety of Cyclo-Z in Patients With Obese Type 2 Diabetes

CompletedNCT02784275

NovMetaPharma Co., Ltd.Diabetes Mellitus Type 2 in Obese

Start: 2016-06-09End: 2017-05-17Updated: 2018-07-12

A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes

CompletedNCT03560271

NovMetaPharma Co., Ltd.Diabetes Mellitus, Type 2

Start: 2018-06-18End: 2019-07-15Updated: 2019-11-18